{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T16:29:28Z","timestamp":1794241768728,"version":"4.9.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.ygyno.2016.02.008","type":"journal-article","created":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T13:02:50Z","timestamp":1455022970000},"page":"247-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Natural history and outcome of neuroendocrine carcinoma of the cervix"],"prefix":"10.1016","volume":"141","author":[{"given":"Benjamin","family":"Margolis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana I.","family":"Tergas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June Y.","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim C.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cande V.","family":"Ananth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred I.","family":"Neugut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn L.","family":"Hershman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2016.02.008_bb0005","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/1097-0142(197612)38:6<2328::AID-CNCR2820380620>3.0.CO;2-J","article-title":"Carcinoid of the uterine cervix: additional observations on a new tumor entity","volume":"38","author":"Albores-Saavedra","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2016.02.008_bb0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00004347-198403010-00005","article-title":"Argyrophilia, serotonin, and peptide hormones in the female genital tract and its tumors","volume":"3","author":"Scully","year":"1984","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2016.02.008_bb0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0090-8258(91)90225-T","article-title":"Small cell carcinoma of the cervix: a clinical and flow-cytometric study","volume":"42","author":"Miller","year":"1991","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.02.008_bb0020","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1002\/1097-0142(197706)39:6<2624::AID-CNCR2820390648>3.0.CO;2-F","article-title":"The prognostic significance of pelvic lymph node morphology in carcinoma of the uterine cervix","volume":"39","author":"van Nagell","year":"1977","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2016.02.008_bb0025","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/cncr.11086","article-title":"Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis","volume":"97","author":"Chan","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2016.02.008_bb0030","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ajog.2010.04.019","article-title":"Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients","volume":"203","author":"Cohen","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2016.02.008_bb0035","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ijgo.2007.06.051","article-title":"Surgical treatment for neuroendocrine carcinoma of the uterine cervix","volume":"99","author":"Kasamatsu","year":"2007","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2016.02.008_bb0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ygyno.2003.12.027","article-title":"Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence","volume":"93","author":"Viswanathan","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.02.008_bb0045","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ygyno.2008.11.010","article-title":"Small cell neuroendocrine carcinoma of the cervix: analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy","volume":"112","author":"Zivanovic","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.02.008_bb0050","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1006\/gyno.2000.6118","article-title":"Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix","volume":"81","author":"Boruta","year":"2001","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.02.008_bb0055","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ygyno.2013.01.014","article-title":"Neuroendocrine carcinoma of the uterine cervix: the role of multimodality therapy in early-stage disease","volume":"129","author":"McCann","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.02.008_bb0060","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0090-8258(02)00150-6","article-title":"Endocrine tumors of the uterine cervix: incidence, demographics, and survival with comparison to squamous cell carcinoma","volume":"88","author":"McCusker","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.02.008_bb0065","unstructured":"The National Cancer Data Base at https:\/\/www.facs.org\/quality programs\/cancer\/ncdb."},{"key":"10.1016\/j.ygyno.2016.02.008_bb0070","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1245\/s10434-007-9747-3","article-title":"The National Cancer Data Base: a powerful initiative to improve cancer care in the United States","volume":"15","author":"Bilimoria","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2016.02.008_bb0075","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1245\/s10434-013-2901-1","article-title":"Comparison of cases captured in the national cancer data base with those in population-based central cancer registries","volume":"20","author":"Lerro","year":"2013","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2016.02.008_bb0080","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijgo.2011.06.010","article-title":"HPV genotyping in neuroendocrine carcinoma of the uterine cervix in northern Thailand","volume":"115","author":"Siriaunkgul","year":"2011","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2016.02.008_bb0085","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1200\/JCO.2003.01.501","article-title":"Small-cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy","volume":"21","author":"Hoskins","year":"2003","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2016.02.008_bb0090","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ygyno.2012.01.012","article-title":"Prognostic significance of adenocarcinoma histology in women with cervical cancer","volume":"125","author":"Galic","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.02.008_bb0095","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ygyno.2011.04.011","article-title":"Neuroendocrine tumors of the gynecologic tract: a Society of Gynecologic Oncology (SGO) clinical document","volume":"122","author":"Gardner","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.02.008_bb0100","first-page":"68","article-title":"Small cell neuroendocrine carcinoma of the cervix: analysis of the prognosis and role of radiation therapy for 43 cases","volume":"33","author":"Lan-Fang","year":"2012","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.02.008_bb0105","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/IGC.0b013e3181ce427b","article-title":"Unfavorable prognosis of small cell neuroendocrine carcinoma of the uterine cervix: a retrospective matched case-control study","volume":"20","author":"Lee","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2016.02.008_bb0110","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00001813-199908000-00003","article-title":"Phase II trial of neoadjuvant chemotherapy in early-stage small cell cervical cancer","volume":"10","author":"Chang","year":"1999","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.ygyno.2016.02.008_bb0115","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1101\/gad.263145.115","article-title":"Origins, genetic landscape, and emerging therapies of small cell lung cancer","volume":"29","author":"Semenova","year":"2015","journal-title":"Genes Dev."},{"key":"10.1016\/j.ygyno.2016.02.008_bb0120","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1200\/JCO.2013.51.4109","article-title":"Southwest Oncology Group S0802: a randomized, phase II trial of weekly topotecan with and without ziv-aflibercept in patients with platinum-treated small-cell lung cancer","volume":"32","author":"Allen","year":"2014","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2016.02.008_bb0125","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1200\/JCO.2010.29.3423","article-title":"Randomized phase II study of bevacizumab in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer: results from the SALUTE trial","volume":"29","author":"Spigel","year":"2011","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2016.02.008_bb0130","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJMoa1309748","article-title":"Improved survival with bevacizumab in advanced cervical cancer","volume":"370","author":"Tewari","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2016.02.008_bb0135","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.critrevonc.2014.03.003","article-title":"Treatment of small cell lung cancer","volume":"91","author":"Morabito","year":"2014","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ygyno.2016.02.008_bb0140","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1158\/2159-8290.CD-12-0112","article-title":"Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1","volume":"2","author":"Byers","year":"2012","journal-title":"Cancer Discov."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816300348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816300348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T11:27:50Z","timestamp":1537010870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825816300348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0090825816300348"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.02.008","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural history and outcome of neuroendocrine carcinoma of the cervix","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}